Next Generation News and Research

RSS
Salix third quarter total product revenue increases 81% to $146.2 million

Salix third quarter total product revenue increases 81% to $146.2 million

Micromet third quarter total revenues decrease to $4.5 million

Micromet third quarter total revenues decrease to $4.5 million

FDA accepts Genentech's vismodegib NDA for review

FDA accepts Genentech's vismodegib NDA for review

University of Houston to enhance cancer research facilities

University of Houston to enhance cancer research facilities

Micromet's blinatumomab data to be reported at 53rd ASH annual meeting

Micromet's blinatumomab data to be reported at 53rd ASH annual meeting

Boston Scientific reports positive long-term data from PERSEUS clinical program

Boston Scientific reports positive long-term data from PERSEUS clinical program

Inova Labs secures $17.5M in Series B round of equity financing

Inova Labs secures $17.5M in Series B round of equity financing

Cordis receives FDA 510(k) clearance for EMPIRA Balloon Catheters

Cordis receives FDA 510(k) clearance for EMPIRA Balloon Catheters

CardioNet third quarter revenue decreases 3.2% to $26.6 million

CardioNet third quarter revenue decreases 3.2% to $26.6 million

DSM and Svelte Medical Systems enter into license and supply agreement

DSM and Svelte Medical Systems enter into license and supply agreement

InfraReDx TVC Imaging System to be exhibited at TCT 2011

InfraReDx TVC Imaging System to be exhibited at TCT 2011

InfraReDx launches enhanced version of LipiScan IVUS Coronary Imaging System

InfraReDx launches enhanced version of LipiScan IVUS Coronary Imaging System

Study: Young adults in the north west of England consume illegal drugs after mephedrone ban

Study: Young adults in the north west of England consume illegal drugs after mephedrone ban

K2M adds two additions to family of ALEUTIAN Interbody Systems for lumbar applications

K2M adds two additions to family of ALEUTIAN Interbody Systems for lumbar applications

Medtronic highlights scientific sessions of interest on program for TCT 2011

Medtronic highlights scientific sessions of interest on program for TCT 2011

Presidio Pharmaceuticals advances with its HCV antiviral drug discovery, development programs

Presidio Pharmaceuticals advances with its HCV antiviral drug discovery, development programs

Edwards Life Sciences heart valve approved in the US

Edwards Life Sciences heart valve approved in the US

Zynex third quarter net revenues increase 42% to $9,427,000

Zynex third quarter net revenues increase 42% to $9,427,000

DexCom signs research and development agreement with Roche

DexCom signs research and development agreement with Roche

SGI HPC systems selected for genomics research at Kyoto University's Institute for Chemical Research

SGI HPC systems selected for genomics research at Kyoto University's Institute for Chemical Research

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.